This virtual event on March 29, 2023 featured presentations by ProQR Management on the company's proprietary Axiomer® RNA editing technology platform, detailed the initial pipeline targets, and provided guidance on the advancement of programs toward the clinic. ProQR also reported its 2022 year-end financials and the extension of its cash runway guidance.
… ProQR Announces Presentations and Investor & Analyst Event at the North American Cystic Fibrosis Conference … announced details about upcoming presentations and an investor & analyst event at the North American Cystic …
… program to enter the clinic Company to host virtual Investor and Analyst Event in December to highlight translational data and … diseases. ProQR will hold a virtual Analyst and InvestorEvent in December to highlight translational …
